Park Medi World IPO Analyzed

Key Points

• Huge demand: 4.11 crore bids against 4.18 crore shares offered.
• IPO subscribed 0.98 times, showing strong investor interest.
• Funds used: debt repayment, hospital expansion, and equipment purchase.
• Promoters hold 95.55% of shares, impacting post-IPO ownership.
• Strong financials: Net profit of Rs 139.14 crore for nine months.
• Anchor investors contributed Rs 275.99 crore before the IPO launch.

IPO Details

The Park Medi World Initial Public Offering (IPO) generated significant interest, with a substantial number of bids received. Investors showed strong confidence in the company’s potential. The IPO’s success demonstrates a growing appetite for healthcare investments.

Specifically, the exchange reported 4,11,32,832 shares bid for, compared to the initial offer of 4,18,18,182 shares. This indicates a high level of demand. The IPO was fully subscribed at 0.98 times, reflecting the positive sentiment.

The IPO period ran from December 10th to December 12th, 2025, offering investors the chance to buy shares at a price band of Rs 154 to Rs 162 per share. Investors could bid for a minimum of 92 shares, and multiples thereof.

The total value of the IPO was up to Rs 770 crore through a fresh issue of equity shares, and an offer for sale worth Rs 150 crore by existing shareholder Dr. Ajit Gupta. These funds are earmarked for several key areas.

The primary uses for the funds raised include Rs 380 crore to repay existing debts, Rs 60.5 crore for developing a new Park Medicity hospital in the National Capital Region (NCR), Rs 27.45 crore for acquiring medical equipment for Park Medi World and its subsidiaries, and the remaining sum for strategic acquisitions and general business purposes.

Dr. Ajit Gupta and Dr. Ankit Gupta, along with the promoter group, own a significant portion of the company – 95.55% of the equity shares before the IPO. After the IPO, their ownership will decrease to approximately 82.89%.

Park Medi World is a leading private hospital chain primarily operating in North India. It operates 14 NABH-accredited multi-specialty hospitals with a total of 3,250 beds, the largest in Haryana. The company provides care across 30+ specialties including internal medicine, neurology, and oncology, supported by a large team of 1,014 doctors and 2,142 nurses.

The company has grown through acquisitions and is currently expanding its reach with new hospitals planned in Ambala, Panchkula, Rohtak, Gorakhpur, and Kanpur, ultimately aiming for a total bed capacity of 4,900 by FY28. Revenue is predominantly driven by internal medicine (29.65%) and bolstered by government healthcare schemes (83.38%). Bed occupancy is currently at 68.14%, with robust outpatient and inpatient volumes of 46,551 and 3,92,049 respectively.

Ahead of the IPO, Park Medi World secured an additional Rs 275.99 crore from 23 anchor investors on December 9th, 2025, by allocating 1.70 crore shares at a price of Rs 162 each.

The company reported strong financial results for the nine months ending June 30, 2025, demonstrating profitability with a consolidated net profit of Rs 139.14 crore and an income from operations of Rs 808.66 crore.

Ultimately, the Park Medi World IPO represents a significant step for the company, providing capital for expansion and solidifying its position in the Indian healthcare market.